Octozi Raises $3M Seed
Octozi, a New York City-based artificial intelligence company that automates clinical development workflows for pharmaceutical sponsors, has raised $3 million in seed funding. The company utilizes agentic AI to streamline the complex data operations associated with clinical trials.
The round was led by Surface Ventures, with participation from Remarkable Ventures.
Octozi plans to use the capital to further develop its platform, which integrates with existing clinical systems to automate the cleaning, reconciliation, review, and reporting of trial data.
Founded by Amit Patel, Octozi is a New York-based software company that provides an artificial intelligence platform for pharmaceutical sponsors and contract research organizations. The platform combines large language models with deterministic clinical algorithms to assist clinical study teams in accelerating data-heavy development workflows.
Funding Details
Company Website: https://octozi.com
Company: Octozi
Raised: $3M
Round: Seed
Funding Date: July 2026
Lead Investor: Surface Ventures
Additional Investors: Remarkable Ventures
Company Website: http://www.octozi.com
Software Category: AI/Healthcare Software